CBD vs Passionflower: Which Is Better for Anxiety and Sleep?
By the PureCraft Editorial Team | Updated October 2026
CBD vs Passionflower: Which Is Better for Anxiety and Sleep?
Walk down the supplement aisle and you will find both passionflower extract and CBD oil marketed for the same thing: quieting anxiety and helping you fall asleep. They come from entirely different plant families and have been used in entirely different traditions — yet modern pharmacology has uncovered a striking overlap in how they work. Both compounds influence GABA-A receptors, the same receptors targeted by benzodiazepines like Xanax. That shared mechanism is the foundation of this comparison, because once you understand it, the real differences — and the case for combining them — become much clearer.
This guide goes deep on both compounds: mechanism, clinical evidence, head-to-head differences, safety considerations, and the honest answer to whether stacking them makes sense. Whether you are managing generalized anxiety, struggling with sleep onset, or just trying to figure out which natural option is worth your money, here is what the science actually shows.
What Is Passionflower and How Does It Work?
Passiflora incarnata — the species with the most research behind it — is a climbing vine native to the southeastern United States and South America. It has a long history in folk medicine across both continents for nervousness and insomnia, and it was listed in the U.S. National Formulary as a sedative until 1936. Contemporary pharmacology has moved well beyond folk observation, and the picture that has emerged is more nuanced than "it calms you down."
Primary Mechanism: GABA-A Positive Allosteric Modulation
Passionflower's main anxiolytic effect comes from flavonoids — primarily chrysin, vitexin, isovitexin, and orientin — that act as positive allosteric modulators at the GABA-A receptor. Specifically, these compounds appear to bind at or near the benzodiazepine-binding site on the GABA-A receptor complex, which enhances the receptor's response to GABA, the brain's primary inhibitory neurotransmitter.
For a look at a nighttime-oriented product format, see Pure Craft CBD and CBN sleep gummies.
There is a nuance worth understanding here: chrysin alone has poor CNS bioavailability when administered in isolation, which historically led researchers to question whether passionflower could really be working through GABA-A at all. The current thinking is that the combination of flavonoids in the whole extract produces synergistic GABA-A enhancement that individual isolated compounds cannot replicate — a common pattern in botanical pharmacology. This is one reason standardized whole-plant extracts tend to outperform isolated chrysin supplements for anxiety.
Secondary Mechanisms
Passionflower also shows mild MAO-A inhibitory activity. MAO-A is the enzyme that breaks down monoamine neurotransmitters including serotonin and norepinephrine, so inhibiting it allows those neurotransmitters to linger longer in synaptic clefts — a mechanism that overlaps with pharmaceutical antidepressants. This contributes to passionflower's mood-stabilizing effect, but it also introduces the drug interaction considerations covered below. Additionally, some research suggests mild kappa-opioid receptor activity, which may contribute to anxiolytic and sedative effects at higher doses.
Clinical Evidence for Passionflower
The landmark clinical trial is Akhondzadeh et al. (2001), a randomized controlled trial that compared passionflower extract to oxazepam (a benzodiazepine commonly used for generalized anxiety disorder) in 36 adults with GAD. Both treatments produced equivalent reductions in anxiety scores over four weeks. The critical finding was that passionflower caused significantly less impairment in job performance than oxazepam — suggesting it hits the anxiolytic target with a better daytime-functioning profile. A second trial from the same group in 2001 found passionflower reduced anxiety in patients experiencing opioid withdrawal, further supporting its GABA-A mechanism (since opioid withdrawal involves GABA dysregulation).
For sleep, the evidence is present but more modest. The GABA-A agonist effect shortens sleep onset latency — how long it takes to fall asleep — and at least one small RCT in adults found that passionflower tea meaningfully improved subjective sleep quality. The effect is real but not dramatic, comparable to low-dose melatonin in magnitude.
For a closer look at available formats and ingredients, browse Pure Craft broad-spectrum CBD oil.
What Is CBD and How Does It Work?
CBD (cannabidiol) is a non-psychoactive cannabinoid from Cannabis sativa that has attracted substantial research attention over the past decade for anxiety, sleep, inflammation, and pain. It does not bind meaningfully to the CB1 receptors that produce THC's high, which is why it does not cause intoxication. What it does do is interact with a surprisingly broad range of receptor systems simultaneously — which is the core of its pharmacological advantage over most single-mechanism botanicals.
CBD's Receptor Profile
Here is the key framing point for this entire comparison: CBD also acts as a positive allosteric modulator at GABA-A receptors. This is the same mechanism as passionflower. Research suggests CBD binds to transmembrane sites on the GABA-A receptor (distinct from the benzodiazepine site where passionflower's flavonoids bind) and enhances GABA-mediated inhibitory tone. So at the foundational level, these two compounds share an anxiolytic mechanism.
But CBD goes further. It is a partial agonist at 5-HT1A serotonin receptors — the same receptors targeted by buspirone, an FDA-approved anxiolytic — which is believed to be central to its anxiolytic and antidepressant-adjacent effects. Learning about CBD for anxiety reveals how this 5-HT1A activity distinguishes CBD from most botanical competitors, since most herbs (including passionflower) do not meaningfully hit this receptor. CBD also modulates the HPA (hypothalamic-pituitary-adrenal) axis, the stress hormone system, which passionflower does not. This HPA modulation is relevant for chronic stress-driven anxiety and is part of why people using CBD for stress often report improvements in rumination and physiological stress response rather than just sedation.
CBD also engages adenosine A1 and A2A receptors (adenosine buildup promotes sleep pressure), TRPV1 ion channels (which play a role in pain and inflammation), and indirectly influences the endocannabinoid system by inhibiting FAAH, the enzyme that breaks down anandamide. The breadth of this target profile means CBD is addressing anxiety and sleep through multiple parallel pathways simultaneously.
Review the full ingredient list, including melatonin, for Pure Craft sleep gummies.
Clinical Evidence for CBD
CBD's clinical evidence base is growing rapidly. A widely cited 2019 study in The Permanente Journal (Shannon et al.) examined CBD in a psychiatric clinic population and found anxiety scores improved in 79% of patients within the first month, and sleep scores improved in 66%. A 2011 RCT (Bergamaschi et al.) found a single 600mg dose of CBD significantly reduced anxiety in patients with social anxiety disorder before a simulated public speaking test — relevant reading alongside deeper coverage of CBD for social anxiety. Preclinical evidence for CBD's effects on CBD for panic attacks is also strong, with animal models showing reduced fear responses and panic-like behaviors at multiple doses. For CBD for sleep, the evidence suggests it is more effective for anxiety-driven insomnia than primary insomnia — it calms the arousal state that keeps people awake rather than directly inducing sleep the way a sedative would.
CBD vs Passionflower: Head-to-Head Comparison
The table below compares the two compounds across the dimensions most relevant to anxiety and sleep.
| Category | CBD | Passionflower |
|---|---|---|
| Primary mechanism | Multi-target: GABA-A, 5-HT1A, HPA axis, adenosine, TRPV1 | GABA-A modulation + mild MAO-A inhibition |
| Anxiety | Strong (5-HT1A + HPA + GABA-A) | Moderate (GABA-A + MAO-A) |
| Sleep | Good (adenosine + GABA-A + anxiety reduction) | Moderate (GABA-A — mainly onset latency) |
| Pain and inflammation | Strong (TRPV1, anandamide, inflammatory pathways) | Minimal |
| SSRI interaction risk | CYP450 metabolic (raises or lowers drug levels) | Theoretical MAO-A (serotonin syndrome risk) |
| Daytime sedation | Mild at typical doses | Mild to moderate |
| RCT evidence for anxiety | Growing body; multiple positive RCTs | Yes — GAD RCT vs. oxazepam (Akhondzadeh 2001) |
| Psychoactivity | None (non-intoxicating) | None (mild sedation only) |
The Key Differences That Matter in Practice
Breadth of effect. Both reduce anxiety through GABA-A modulation — the shared mechanism cannot be overstated. But CBD's 5-HT1A activity adds a dimension that passionflower simply does not have. The 5-HT1A receptor is involved in chronic anxiety, fear memory consolidation, and mood regulation. Hitting it likely explains why CBD appears more effective for anxiety that has a worry-and-rumination quality, while passionflower may be sufficient for situational or acute nervousness where you mainly need the GABA-A brake applied.
HPA axis modulation. CBD's influence on cortisol and the stress hormone axis is another capability passionflower lacks. For people whose anxiety is rooted in chronic stress — elevated baseline cortisol, difficulty recovering from stressors, perpetual low-grade activation — this matters. Passionflower does not address that upstream hormonal driver.
To compare labeled CBD content and ingredients, see Pure Craft CBD oil product details.
Sleep quality vs. sleep onset. For sleep, the distinction is important. Passionflower's GABA-A effect shortens the time it takes to fall asleep. CBD does that too, but it also appears to improve sleep architecture — the quality of sleep, including slow-wave and REM distribution — through adenosine receptor engagement and by reducing the anxiety that causes fragmented sleep. For people comparing options, those asking "how do CBD and passionflower compare to CBD vs melatonin?" will find all three have different mechanisms and different optimal use cases.
Sedation profile. Passionflower tends to be more sedating than CBD at equivalent doses. This is partly because the GABA-A effect of passionflower's flavonoids is more direct and less nuanced than CBD's allosteric modulation, and partly because passionflower does not have the alerting serotonergic dimension that CBD brings via 5-HT1A. For daytime anxiety, CBD is often better tolerated. For nighttime use specifically, passionflower's stronger sedating character may actually be an advantage.
Pain co-management. CBD's TRPV1 and anandamide-pathway effects give it meaningful analgesic and anti-inflammatory properties that passionflower does not share. For anyone whose anxiety or sleep disruption has a pain component — chronic pain, muscle tension, inflammation-driven sleep disruption — CBD has a clear edge.
Those comparing nighttime gummy formulations can examine Pure Craft CBD + CBN gummies with melatonin.
Drug Interactions and Safety: Important Differences
Both compounds are generally well-tolerated for healthy adults not on other medications. But the interaction profiles diverge meaningfully.
Passionflower interactions. The MAO-A inhibitory activity creates theoretical risk when combined with SSRIs, SNRIs, or MAOIs — a combination that could contribute to serotonin syndrome. This risk is considered theoretical because the MAO inhibition is mild, but it is real enough that clinicians routinely flag it. Passionflower also should not be combined with benzodiazepines or barbiturates because of additive CNS depression via shared GABA-A mechanism. It is contraindicated in pregnancy due to uterotonic alkaloids in the plant. Dose standardization is also inconsistent across commercial products — the ratio and concentration of active flavonoids varies between brands, which complicates dosing.
CBD interactions. CBD's primary interaction concern is CYP450 enzyme inhibition — specifically CYP3A4 and CYP2C19 — which means it can raise or lower the blood levels of medications metabolized by those enzymes. This includes many antidepressants, antiepileptics, blood thinners, and statins. Notably, CBD does not carry the MAO-A serotonin syndrome risk that passionflower does, which makes it somewhat safer alongside SSRIs in theory (though CYP450 interaction with those same SSRIs still warrants monitoring). Understanding how to take CBD oil correctly — including timing relative to other medications — matters particularly if you are on prescription drugs.
Can You Take CBD and Passionflower Together?
This is a question that deserves an honest answer rather than a marketing one. Because both compounds enhance GABA-A activity — CBD through transmembrane allosteric modulation and passionflower's flavonoids through the benzodiazepine-adjacent site — there is a real possibility of additive or synergistic sedation when they are combined. Whether that is a benefit or a problem depends entirely on context.
If you are exploring an oil format, review Pure Craft broad-spectrum CBD oil before choosing a product.
For nighttime use in a healthy adult not on other CNS-active medications, combining them is unlikely to be dangerous. Many sleep formulations on the market already do exactly this — layering GABA-A modulators at modest doses. The combined sedation effect may actually be the point. At typical OTC doses of each, most adults will tolerate the combination without incident.
The concern rises significantly if you are also taking benzodiazepines, sedative antihistamines, sleep medications (like zolpidem), opioids, alcohol, or any other CNS depressant. In that situation, layering two more GABA-A modulators is pushing in a direction that can meaningfully increase sedation, respiratory depression risk, and cognitive impairment.
Passionflower's MAO-A inhibitory activity also adds interaction complexity to the combination. CBD on its own has no meaningful MAO activity — it does not compound that particular risk. But if you are combining CBD plus passionflower plus an SSRI, you have introduced a theoretical serotonin-related interaction via the passionflower. This is still considered low risk given the mildness of passionflower's MAO inhibition at standard doses, but it is not zero, and a prescribing clinician should know you are using both.
For a look at a nighttime-oriented product format, see Pure Craft CBD and CBN sleep gummies.
The practical summary: for a healthy adult using nighttime supplements for anxiety-driven sleep difficulty, taking both is a reasonable experiment. Start with the lowest effective dose of each, observe how sedated you feel, and do not add either to an existing medication regimen without talking to your doctor first.
Who Should Use Which?
Passionflower may be the better fit if: You need something for occasional situational anxiety or sleep onset difficulty, you prefer a single-mechanism botanical with a longer history of clinical use, you are not on SSRIs or MAOIs, and cost efficiency matters since passionflower is significantly less expensive than quality CBD.
CBD may be the better fit if: Your anxiety is chronic rather than situational, you want coverage for both anxiety and pain, you need daytime use without meaningful sedation, you want a compound with more diverse receptor coverage and a more resilient evidence base. Finding the best CBD oil for your needs — whether that is a broad-spectrum, full-spectrum, or isolate product — matters more than it might for passionflower, since product quality and cannabinoid profile significantly affect CBD outcomes.
Both together may make sense if: You are primarily using both at night for sleep, you want GABA-A modulation plus 5-HT1A coverage, and you are not on other sedating medications or SSRIs.
The Bottom Line
CBD and passionflower are not competing products in the way supplement marketing often frames them. They share a core mechanism — GABA-A positive allosteric modulation — and both produce real, clinically documented anxiolytic effects. The difference is one of depth and breadth. Passionflower does one thing well: enhance GABA-mediated inhibition, with a modest assist from MAO-A. CBD does that plus 5-HT1A serotonin agonism, HPA axis modulation, adenosine engagement, and TRPV1 activity.
You can examine the serving information for Pure Craft CBD oil to understand how this format is labeled.
For mild, situational anxiety and sleep onset difficulty, passionflower is a legitimate, evidence-backed option at a lower price point. For chronic anxiety, stress-driven sleep disruption, or concurrent pain, CBD's broader mechanism profile gives it a meaningful advantage. The combination is reasonable for most healthy adults at standard doses — just more sedating than either alone, which is the feature for nighttime use and the caution for daytime use.
As always: the supplement that works is the one that fits your specific biology, lifestyle, and medical situation. Neither CBD nor passionflower is a substitute for working with a clinician on significant anxiety disorders, but both are worth understanding as tools in that broader toolkit.
Related Articles
- CBD for Panic Attacks: What the Research Really Shows
- CBD vs. Melatonin for Sleep: Which Works Better? | PureCraft CBD
- CBD for Panic Attacks: What the Research Really Shows
- CBD for Social Anxiety: Does It Actually Help?
- CBD vs Melatonin: Which Is Better for Sleep Architecture? | PureCraft CBD
- How to Take CBD Oil: Sublingual Technique, Timing, and Dosing Guide 2027 | PureCraft CBD
- How to Read CBD Product Labels for Safety and Quality
Sources and References
- Akhondzadeh S, et al. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26(5):363–367. PubMed
- Akhondzadeh S, et al. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial. J Clin Pharm Ther. 2001;26(5):369–373. PubMed
- Ngan A, Conduit R. A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata (passionflower) herbal tea on subjective sleep quality. Phytother Res. 2011;25(8):1153–1159. PubMed
- Shannon S, et al. Cannabidiol in anxiety and sleep: a large case series. Perm J. 2019;23:18-041. PubMed
- Bergamaschi MM, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology. 2011;36(6):1219–1226. PubMed
- Bakas T, et al. The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA-A receptors. Pharmacol Res. 2017;119:358–370. PubMed
- Zanoli P, Avallone R, Baraldi M. Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia. 2000;71 Suppl 1:S117–123. PubMed
- Ibeas Bih C, et al. Molecular targets of cannabidiol in neurological disorders. Neurotherapeutics. 2015;12(4):699–730. PubMed
- Blessing EM, et al. Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics. 2015;12(4):825–836. PubMed